IP Library Granted Patent US 12,618,107
Granted Patent B2
US 12,618,107 · App. 17/594,534 · Granted May 5, 2026

Methods for forming adapter ligated nucleic acid molecules

Inventors: Shengxi Guan (Stoneham, MA); Sean Maguire (Gloucester, MA)
Assignee: New England Biolabs, Inc.
C12Q1/6855C12N15/1093C12N15/1096C12Q2525/191
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,618,107
App. No.
17/594,534
Granted
May 5, 2026
Kind
B2
Abstract

Compositions and methods of use are provided that among other things, allow for efficient adapter ligation to small RNAs. Embodiments of the compositions include partially double stranded polynucleotides for use as 3′ adapters that contain a cleavable linker positioned between a single-stranded region and a double-stranded region. Upon ligating the 3′ adapters, the single-stranded region is released by cleaving the cleavable linker.

Claims (22)

1 . A method comprising:

ligating 3′ adaptor molecules to the ends of members of a population of single stranded target polynucleotides, wherein the 3′ adaptor molecules comprise:

a top strand and a bottom strand, wherein:

(a) the top strand comprises a nucleic acid sequence that is complementary to a portion of the nucleic acid sequence of the bottom strand, such that the top strand and bottom strand form a double-stranded region by complementary base-pairing; and

(b) the bottom strand comprises: (i) a non-complementary 3′ single-stranded extension, (ii) a sequence of at least 4 degenerate nucleotides, wherein the at least 4 degenerate nucleotide sequence is a random sequence, wherein the random sequences the 3′ adaptor molecules bind to members of the population of single stranded target polynucleotides; and (iii) a site-specific cleavable sequence or nucleotide at or near the junction between the double-stranded region and the single-strand extension, suitable f removing the single-strand extension by cleavage to form a double-stranded region at t 3′ end of the target polynucleotides;

cleaving the single-strand extensions of the ligated 3′ adaptors;

ligating 5′ adaptors to the 5′ ends of the single stranded target polynucleotides, wherein the 5′ polynucleotide adaptors comprise a top strand and a complementary bottom strand with the bottom strand having a 5′ single-strand extension containing degenerate bases.

2 . The method according to claim 1 , wherein the single stranded target polynucleotides are RNA.

3 . The method according to claim 2 , wherein the polynucleotides are members of a library.

4 . The method according to claim 2 , wherein the polynucleotides are members of a population of RNAs that are variable in size and concentration.

5 . The method according to claim 4 , further comprising, after ligating the 3′ adaptor molecules, cleaving the single-strand extensions of the ligated 3′ adaptors, and ligating 5′ adaptors: reverse transcribing the RNA and forming a cDNA library.

6 . The method according to claim 5 , further comprising: performing the steps of ligating the 3′ adaptor molecules, ligating the 5′adaptors and reverse transcribing the RNA in a one pot workflow.

7 . The method according to claim 5 , wherein a purification step is not performed prior to reverse transcribing the RNA and forming the cDNA library.

8 . The method according to claim 2 , wherein the RNA is sRNA.

9 . The method according to claim 1 , wherein the step of cleaving the single-strand extensions of the ligated 3′ adaptors comprises cleaving a site-specific cleavable sequence or nucleotide in the 3′ adaptors with a nicking restriction endonuclease.

10 . The method according to claim 1 , wherein the step of cleaving the single-strand extensions of the ligated 3′ adaptors comprises cleaving a site-specific cleavable sequence or nucleotide in the 3′ adaptors with a glycosylase/lyase.

11 . The method according to claim 1 , wherein the single stranded target polynucleotides are RNA in a body fluid.

12 . The method according to claim 1 , wherein the single stranded target polynucleotides are RNA in a cell lysate.

13 . The method of claim 1 , wherein cleaving the single-strand extensions of the ligated 3′ adaptors is performed before ligating 5′ adaptors.

14 . The method of claim 1 , wherein cleaving the single-strand extensions of the ligated 3′ adaptors is performed after ligating 5′ adaptors.

15 . The method of claim 1 , wherein the top strand and bottom strand of the 3′ adaptor molecules are formed from two polynucleotide strands.

16 . The method of claim 1 , wherein the top strand and bottom strand of the 3′ adaptor molecules are formed from a single polynucleotide strand.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2021
From: GUAN, SHENGXI; MAGUIRE, SEAN
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 057860/0874 →
Continuity (3)
Continuation 16796113 · Feb 20, 2020
Provisional Application 62839191 · Apr 26, 2019
Related Publication 20220213539A1 · Jul 7, 2022
References Cited (25)
US 8163479B2 · Jaccard et al. · 2012 [cited by applicant]
US 8178314B2 · Kindermann et al. · 2012 [cited by applicant]
US 8227602B2 · Gautier et al. · 2012 [cited by applicant]
US 8975388B2 · Zichi et al. · 2015 [cited by applicant]
US 11390915B2 · Guan · 2022 [cited by examiner]
US 20130261027A1 · Li et al. · 2013 [cited by applicant]
US 20140357528A1 · Robb et al. · 2014 [cited by applicant]
US 20160265031A1 · Liu et al. · 2016 [cited by applicant]
US 20170145500A1 · Myers et al. · 2017 [cited by applicant]
US 20180010178A1 · Charizanis et al. · 2018 [cited by applicant]
US 20190194649A1 · Raine · 2019 [cited by examiner]
WO 2012158603A2 · 2012 [cited by applicant]
WO WO2018193233A1 · 2018 [cited by examiner]
Sultan et al., “Influence of RNA extraction methods and library selection schemes on RNA-seq data,” BMC Genomics, vol. 15, pp. 1-13. (Year: 2014). [cited by examiner]
Bottani, et al., Journal of Clinical Medicine, 8, 1661 (2019). [cited by applicant]
Keam, et al., Life 5, 1638-1651 (2015). [cited by applicant]
Kumar, et al., BMC Biology, 12, 78 (2014). [cited by applicant]
Shigematsu, et al., Gene Regulation and Systems Biology, 9, 27-33 (2015). [cited by applicant]
Maguire, et al, Nucleic Acids Research, 48, 14, e80 (2020). [cited by applicant]
Wu, et al, BMC Genomics, 19, 1, 1-12, 2018. [cited by applicant]
Hafner, et al., RNA, 17, 9, 1697-1712, 2011. [cited by applicant]
Gansauge, et al, Nucleic Acids Research, gkx033, 2017. [cited by applicant]
Giraldez, et al., Nature Biotechnology, 36, 8, 476-757, 2018. [cited by applicant]
Xu, et al., Methods in next generation sequencing, 2, 1-10, 2015. [cited by applicant]
Yau, et al., The FEBS Journal, 285, 19, 3669-3682, 2018. [cited by applicant]